Niche Market Focus Entegrion specializes in developing innovative devices and biological technologies targeting unmet medical needs with limited competition, presenting unique sales opportunities in specialized and emerging medical fields.
Expanding Product Portfolio The launch of the VCM Vet viscoelastic coagulation testing platform indicates a strategic expansion into animal health markets, creating potential cross-selling opportunities for existing or new product lines in veterinary diagnostics.
Healthy Revenue and Funding With revenues ranging from 10 to 25 million dollars and recent funding of 14 million dollars, Entegrion demonstrates financial stability and growth potential that can support sales initiatives for innovative biotech solutions.
Industry Alignment Positioned among strong competitors like Baxter, Abbott, and Johnson & Johnson, Entegrion offers specialized biotech solutions that can appeal to hospitals, clinics, and research institutions seeking advanced and targeted medical technologies.
Technology-Driven Approach Utilizing a robust tech stack including cloud-based and web technologies, Entegrion's emphasis on innovative development and data integration presents sales opportunities in digital health solutions and tech-enabled medical technologies.
$10M$25M
$10B
$10B
$10B
$500M$1B
$10B
$10B
$100M$250M
$1B$10BEntegrion, Inc. uses 8 technology products and services including RSS, Cloudflare, oEmbed, and more. Explore Entegrion, Inc.'s tech stack below.
| Entegrion, Inc. Email Formats | Percentage |
| FLast@entegrion.com | 33% |
| First.Last@entegrion.com | 25% |
| Last@entegrion.com | 9% |
| FLast@entegrion.com | 33% |
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Entegrion identifies, invents and systematically develops device and biological technologies to meet clearly defined medical needs. Our pipeline is distinguished by its uniqueness--- we pursue areas with limited competition and profound needs. We design efficient and focused development plans to assure that the products we deliver perform as intended and are ready for market. Twitter @entegrioninfo
Company Overview
Funding & FinancialsEntegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.
Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsEntegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.
Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com